Peter Weib
Papers
1
Total Citations
3
H-Index
1
About
Peter Weib is a urologic surgeon and researcher whose work centers on optimizing surgical outcomes in prostate cancer care, with a particular focus on robot-assisted radical prostatectomy (RARP) and the role of neoadjuvant hormonal therapy (NHT). His research addresses a critical clinical question: whether administering hormonal therapy before surgery improves outcomes for high-risk prostate cancer patients. In his most-cited study, "Effect of Neoadjuvant Hormonal Therapy on the Postoperative Course for Patients Undergoing Robot-Assisted Radical Prostatectomy" (2023), Weib systematically evaluates whether NHT facilitates surgical resection and enhances local tumor control. His findings contribute nuanced evidence to a debated area, showing that while NHT may aid surgical technique, its impact on overall cancer survival remains uncertain. With 3 citations in a short time, this work signals growing interest among urologic oncologists. Weib’s research is vital for surgeons weighing preoperative treatment strategies, and his careful analysis helps clarify the risks and benefits of combining hormonal therapy with robotic surgery. His work exemplifies the precision medicine approach needed to refine prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1